DIFFERENTIAL SUPPRESSION OF TESTOSTERONE AND ESTRADIOL IN HIRSUTE WOMEN WITH THE SUPERACTIVE GONADOTROPIN-RELEASING HORMONE AGONIST LEUPROLIDE

被引：47
|
作者：
RITTMASTER, RS [1 ]
机构：
[1] DALHOUSIE UNIV, DEPT MED, DIV ENDOCRINOL, HALIFAX B3H 4H2, NS, CANADA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1988年 / 67卷 / 04期
关键词：
D O I：
10.1210/jcem-67-4-651
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：651 / 655
页数：5
相关论文
共 50 条
  • [21] CONVERSION OF A GONADOTROPIN-RELEASING HORMONE ANTAGONIST TO AN AGONIST
    CONN, PM
    ROGERS, DC
    STEWART, JM
    NIEDEL, J
    SHEFFIELD, T
    NATURE, 1982, 296 (5858) : 653 - 655
  • [22] A Semi-Mechanistic Integrated Pharmacokinetic/Pharmacodynamic Model of the Testosterone Effects of the Gonadotropin-Releasing Hormone Agonist Leuprolide in Prostate Cancer Patients
    Chay Ngee Lim
    Ahmed Hamed Salem
    Clinical Pharmacokinetics, 2015, 54 : 963 - 973
  • [23] PULSATILE ADMINISTRATION OF GONADOTROPIN-RELEASING HORMONE AGONIST TO GILTS ACTIVELY IMMUNIZED AGAINST GONADOTROPIN-RELEASING HORMONE
    TRAYWICK, GB
    ESBENSHADE, KL
    JOURNAL OF ANIMAL SCIENCE, 1988, 66 (09) : 2209 - 2215
  • [24] Subcutaneous administration of a depot gonadotropin-releasing hormone agonist induces profound reproductive axis suppression in women
    Filicori, M
    Cognigni, GE
    Arnone, R
    Pocognoli, P
    Tabarelli, C
    Ciampaglia, W
    Taraborelli, S
    Casadio, P
    FERTILITY AND STERILITY, 1998, 69 (03) : 443 - 449
  • [25] MODULATION OF PITUITARY GONADOTROPIN RESPONSE TO GONADOTROPIN-RELEASING HORMONE BY ESTRADIOL
    KEYE, WR
    JAFFE, RB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 38 (05): : 805 - 810
  • [26] A Semi-Mechanistic Integrated Pharmacokinetic/Pharmacodynamic Model of the Testosterone Effects of the Gonadotropin-Releasing Hormone Agonist Leuprolide in Prostate Cancer Patients
    Lim, Chay Ngee
    Salem, Ahmed Hamed
    CLINICAL PHARMACOKINETICS, 2015, 54 (09) : 963 - 973
  • [27] Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes
    Weitzman, Vanessa N.
    Engmann, Lawrence
    DiLuigi, Andrea
    Maier, Donald
    Nulsen, John
    Benadiva, Claudio
    FERTILITY AND STERILITY, 2009, 92 (01) : 226 - 230
  • [28] SUPPRESSION OF LUTEAL ESTRADIOL RECEPTORS AND PROGESTERONE SYNTHESIS BY A GONADOTROPIN-RELEASING HORMONE AGONIST (WY-40972) DURING MIDGESTATION
    SRIDARAN, R
    MAHESH, VB
    BIOLOGY OF REPRODUCTION, 1989, 40 (02) : 276 - 282
  • [29] Effectiveness and limitations of the use of the gonadotropin-releasing hormone agonist leuprolide acetate in the diagnosis of delayed puberty in males
    Lanes, R
    Gunczler, P
    Osuna, JA
    Palacios, A
    Carrillo, E
    Ramirez, X
    Garcia, C
    Paoli, M
    Villaroel, O
    HORMONE RESEARCH, 1997, 48 (01) : 1 - 4
  • [30] Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response
    Chang, Frank E.
    Beall, Stephanie A.
    Cox, Jeris M.
    Richter, Kevin S.
    DeCherney, Alan H.
    Levy, Michael J.
    FERTILITY AND STERILITY, 2016, 106 (05) : 1093 - +
12345